Friday October 23, 2020

'Irish drug approvals remain turgid with little transparency'

The knowledge that treatment exists, but isn’t available to you, is likely to become more common, writes Susan Mitchell

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
26th July, 2017

As pharma companies in Ireland grow impatient over our lethargic and bureaucratic medicine approvals process, their counterparts in the UK are going to court in an attempt to stop the NHS from imposing new limits on the price it will pay for medicines.

The unprecedented legal action follows a new rule that allows the NHS to consider delaying or restricting funding for medicines already deemed good value for money by the drug assessment body -...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Related Stories

Demand continues to outstrip supply in both residential and PRS markets, while developers adapt new build designs to take the pandemic into account

Tina-Marie O'Neill | 1 month ago

Several strategic changes offer an opportunity for positive reform of planning and development

Niall Byrne | 1 month ago

The United States cannot defeat the pandemic like a military foe but it can learn from looking back at its post-war economic recovery

Todd G Buchholz | 2 months ago